XML 139 R16.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

NET INCOME (LOSS) PER SHARE | 12 Months Ended
--- | ---
Oct. 31, 2019
Earnings Per Share [Abstract] |
NET INCOME (LOSS) PER SHARE | NET INCOME PER SHARE The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented below.
| Years Ended October 31,
| 2019 |  | 2018 |  | 2017
| (in millions)
Numerator: |  |  |  |  |
Net income | $ | 1,071 |  |  | $ | 316 |  |  | $ | 684 |
Denominators: |  |  |  |  |
Basic weighted average shares | 314 |  |  | 321 |  |  | $ | 322 |
Potential common shares — stock options and other employee stock plans | 4 |  |  | 4 |  |  | 4 |
Diluted weighted average shares | 318 |  |  | 325 |  |  | 326 |
The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense and the dilutive effect of in-the-money options and non-vested restricted stock units. Under the treasury stock method, the amount the employee must pay for exercising stock options and unamortized share-based compensation expense collectively are assumed proceeds to be used to repurchase hypothetical shares. An increase in the fair market value of the company's common stock can result in a greater dilutive effect from potentially dilutive awards. We exclude stock options with exercise prices greater than the average market price of our common stock from the calculation of diluted earnings per share because their effect would be anti-dilutive. In addition, we exclude from the calculation of diluted earnings per share, stock options, ESPP, LTPP and restricted stock awards whose combined exercise price and unamortized fair value collectively were greater than the average market price of our common stock because their effect would also be anti-dilutive. In 2019, 2018 and 2017, we issued approximately 2 million, 2 million and 3 million, of share-based awards, respectively. For the years ended 2019, 2018 and 2017, the impact of the anti-dilutive potential common shares that were excluded from the calculation of diluted earnings per share was not material.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration